Finland· FI-REL-REL54206
Hemosilate Vet
A etamsylaatti product containing etamsylate, registered in Finland by Ecuphar Veterinaria S.L.U.. The same ATC class is registered in 2 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Etamsylate is registered in 2 of 19 countries.
Countries holding a registration under ATC QB02BX01 (etamsylaatti), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 1 of them publish a price we can compare per daily dose
Etamsylate · ATC QB02BX01
2 / 19 countries
- Denmark
- Finlandprice
The record
At a glance
Fimea (Finland)- Active substance
- Etamsylate
- Manufacturer
- Ecuphar Veterinaria S.L.U.
- Country
- Finland (FI)
- ATC code
- QB02BX01
- ATC class
- Etamsylaatti
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Etamsylate in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaCYCLONAMINEFarmaceutyczna Spółdzielnia Pracy Galena, Wrocław
- United KingdomDicynene 250mg/2ml solution for injection ampoulesImported (India)
- PolandCyclonamineFarmaceutyczna Spółdzielnia Pracy GALENA
- SwitzerlandDicynone
- FranceDICYNONE 250 mg, compriméOMEDICAMED UNIPESSOAL (PORTUGAL)
- BelgiumDicynone 250 mgOMEDICAMED Unipessoal
Authorised across Europe · EMA
The same active substance is authorised in 12 EEA countries. Names it is sold under:
- Belgium · Dicynone
- Bulgaria · Дицинон, Циклонамин
- Czechia · Cyclonamine, Dicynone 250
- France · Dicynone
- Hungary · Dicynone
- Lithuania · Dicynone
- Luxembourg · Dicynone®
- Latvia · Dicynone
- Poland · Cyclonamine, Cycloreg
- Romania · Etamsilat Zentiva
- Slovenia · Dicynone
- Slovakia · Cyclonamine, Dicynone 500
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b2e9a0df-1df8-4e8e-aead-5f15b6c31924 GET /v1/drugs/b2e9a0df-1df8-4e8e-aead-5f15b6c31924?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "injektioneste, liuos",
"route": "Laskimoon",
"ddd_unit": null,
"strength": "125 mg/ml",
"atc_label": "Etamsylaatti",
"ma_number": "36810",
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": null,
"fimea_rel_id": "REL54206",
"authorised_at": "2020-08-31"
}See everything about etamsylate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.